GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmena SA (WAR:PHR) » Definitions » Sale Of Business

Pharmena (WAR:PHR) Sale Of Business : zł0.00 Mil (TTM As of Sep. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Pharmena Sale Of Business?

Pharmena's sale of business for the three months ended in Sep. 2024 was zł0.00 Mil. It means Pharmena gained zł0.00 Mil from selling business. Pharmena's sale of business for the trailing twelve months (TTM) ended in Sep. 2024 was zł0.00 Mil.

Compared with last quarter (zł0.00 Mil in Jun. 2024 ), Pharmena gained the same money from selling business in Sep. 2024 (zł0.00 Mil).

Pharmena Sale Of Business Historical Data

The historical data trend for Pharmena's Sale Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmena Sale Of Business Chart

Pharmena Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Business
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Pharmena Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Sale Of Business Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Pharmena Sale Of Business Calculation

The amount earned to sell business.


Sale Of Business for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was zł0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmena Sale Of Business Related Terms

Thank you for viewing the detailed overview of Pharmena's Sale Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmena Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmena SA (WAR:PHR) » Definitions » Sale Of Business
Comparable Companies
WAR:PUR WAR:RDG WAR:GX1 WAR:NNG WAR:SCS WAR:PFM WAR:URT WAR:MOC WAR:BCX WAR:PTG OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
Ulica Wolczanska 178, Lodz, POL, 90-530
Website
http://www.pharmena.pl
Pharmena SA produces cosmeceuticals and pharmaceuticals. The company's activity focuses on three areas such as research in the USA and Canada on the application of selected pyridinium salts in medicine in order to develop an anti-atherosclerosis drug on a global scale, Production and sales of innovative patented dermocosmetics and introduction into the market of an innovative dietary supplement for atherosclerosis prophylaxis. Its products include Menavitin, Dermena, Allerco and Thermi.